Blockchain data protection system to be installed in multiple Ashley HomeStore Locations

PALM BAY, FL / ACCESSWIRE / August 26, 2020 / Sollensys Corp. (OTC PINK:SOLS) Sollensys Corp (the "Company") is pleased to announce that its new Blockchain Archive Server™ is now being installed at multiple retail locations as a reliable solution for the persistent threat of malware and ransomware. The pilot program begins with the installation of the Company's Blockchain Archive Server™ technology to protect SFTF, LLC, which operates 5 Ashley HomeStore Outlets in Jacksonville Florida.

The Blockchain Archive Server™ uses blockchain technology to maintain a redundant, secure and immutable backup of data. Redundant backups and the blockchain work together to assure not only the physical security of the database but also the integrity of the information held within.

The Blockchain Archive Server™ offers a turn-key, off-the-shelf, blockchain solution that works with virtually any hardware and software combinations currently used in commerce, without the need to replace or eliminate any part of the client's data security that is being utilized.

Don Beavers, CEO of Sollensys Corp., remarks, "We are extremely pleased at the opportunity to help SFTF, LLC with their Ashley HomeStore operations to keep their data safe. Their adoption of blockchain technology places them at the innovation forefront as we look forward to a long and expanding relationship."

Chris Caprio, President of SFTF, Ashley HomeStores – Regional Corporate Offices stated, "We consider our investment in the Blockchain Archive Server™ technology to be simply an act of good stewardship in regards to the safeguarding of our customers and employees confidential information. For data within the retail segment, actually every business segment, blockchain is the next logical step in advancing data security.

The Blockchain Archive Server™ is available across the United States and Canada through the newly established network of Sollensys Corp. authorized distributors.

ABOUT SOLLENSYS CORP.

New management has taken control of the company with a focus on data management and blockchain systems developed in the United States. (see: www.sollensys.com)

ABOUT ASHLEY HOMESTORE

Ashley HomeStore is the #1 furniture and mattress retailer in America and the #1 selling furniture store brand in the World. Ashley HomeStore has five locations in Jacksonville, Florida (St. Johns Town Center, River City Marketplace, Orange Park @ I-295, Glynn Isles Market (Brunswick GA)) and the recent Ashley HomeStore Outlet at Southside and Atlantic Blvd. The retailer is an exclusive provider of furniture from Ashley Furniture Industries, Inc., the largest furniture manufacturer in North America. For more information on Ashley HomeStore and its products, visit their website at www.AshleyHomeStore.com.

Forward Looking Statements: Certain information in this press release relating to the Company contains forward-looking statements. All statements other than statements of historical facts included herein are forward-looking statements. In some cases, forward-looking statements can be identified by words such as "believe," "expect," "anticipate," "plan," "potential," "continue" or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Readers should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. The Company is under no obligation (and expressly disclaim any such obligation) to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Investor Relations:

Sollensys Corp.
866.438.7657
www.sollensys.com
IR@sollensys.com

SOURCE: Sollensys Corp.

ReleaseID: 603452

TORONTO, ON / ACCESSWIRE / August 26, 2020 /Titan Medical Inc. ("Titan" or the "Company") (TSX:TMD) (NASDAQ:TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, today announced that it is scheduled to present at the LD 500 investor conference on Wednesday, September 2, 2020 at 11:20 AM ET. David McNally, President and CEO of Titan will be presenting to a live virtual audience available by webcast at http://www.webcaster4.com/webcast/page/2019/36162.

The LD 500 Virtual Conference will take place from September 1 – 4, 2020. To register for the conference visit https://ld500.ldmicro.com/.

View Titan's profile at http://www.ldmicro.com/profile/TMDI.

Profiles powered by LD Micro – News Compliments of Accesswire

About Titan

Titan Medical Inc. is focused on robotic-assisted technologies for application in minimally invasive surgery ("MIS"). Titan is developing a single-port robotic surgical system comprised of a surgeon-controlled patient cart that includes a dual-view camera system with 3D and 2D high-definition vision systems and multi-articulating instruments for performing MIS procedures, and a surgeon workstation that provides an ergonomic interface to the patient cart and a 3D high-definition endoscopic view of the MIS procedure. Titan intends to initially pursue gynecologic surgical indications for use of its single-port robotic surgical system.

For more information, please visit the Company's website at www.titanmedicalinc.com.

About LD Micro

Back in 2006, LD Micro began with the sole purpose of being an independent resource to the microcap world. What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space. The upcoming "500" in September 2020 is LD Micro's most ambitious project yet, and the first event that is accessible to everyone.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Forward-Looking Statements

This news release and the referenced presentation contain "forward-looking statements" within the meaning of applicable Canadian and U.S. securities laws. Such statements reflect the current expectations of management of the Company's future growth, results of operations, performance and business prospects and opportunities. Wherever possible, words such as "may", "would", "could", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate", "potential for" and similar expressions have been used to identify these forward-looking statements. These statements reflect management's current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the "Risk Factors" section of the Company's Annual Report for the year ended December 31, 2019 (which may be viewed at www.sedar.com and at www.sec.gov). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results, performance, or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. Except as required by law, the Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Contact:

Stephen Randall
Chief Financial Officer
+1-416-548-7522
stephen@titanmedicalinc.com

SOURCE: Titan Medical Inc. via LD Micro

ReleaseID: 603453

IRVINE, CA / ACCESSWIRE / August 26, 2020 / Identillect Technologies Corp. (the "Company" or "Identillect") (TSXV:ID), a trusted leading provider of compliant email security, is pleased to provide a corporate update as Covid-19 continues to affect businesses throughout the world, and cyberattacks are on the rise.

The FBI recently reported that the number of complaints about cyberattacks to their Cyber Division is up to as many as 4,000 a day, a 400% increase from what they were seeing prior to the Covid-19 pandemic. Interpol is also seeing an "alarming rate of cyberattacks aimed at critical infrastructure." These attacks are targeting all types of businesses.

Since the onset of Covid-19, Identillect has experienced some customer loss, primarily due to business closure(s), but has more than offset these losses with growth in new verticals, such as medical and insurance services. Identillect is capitalizing on the growth in subscribers from the insurance services sector, by preparing to launch a promotion to 90,000 insurance agents represented by NAPA (National Association of Professional Insurance Agents).

Identillect also continues to focus on Bar Associations where it already represents 19 state bars. Identillect has been working with the state bars to inform their members of the benefits of using Identillect Technologies' Delivery Trust® proprietary e‐mail encryption technology. In coordination with the state bars, Identillect is about to launch a promotion to 280,000 bar members throughout the 19 state bars. Todd Sexton, the Company's CEO stated, "We are very excited to be working so closely with our state bars and are confident that these promotional efforts will result in a number of new Identillect subscribers prior to the end of fiscal 2020."

Identillect also wishes to announce that Gerald Hetrick has resigned from its Board of Directors. Identillect would like to thank Mr. Hetrick for his years of service to the Company.

About Identillect

Identillect Technologies is the leading provider of email encryption service Delivery Trust®, empowering enterprises of all sizes to protect their business and their client's critical information against cyber security attacks.

Delivery Trust® is an award-winning, multi-platform plug-in, which gives users complete control of their emails, for one low price. One simple integration complies with all regulations and most importantly provides peace of mind.

For more information, or your free trial, please visit www.identillect.com

On Behalf of the Board of Directors of:

IDENTILLECT TECHNOLOGIES CORP.

Todd Sexton
Chief Executive Officer
Tel: (949) 468-7878
Email: todd.sexton@identillect.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

SOURCE: Identillect Technologies Corp.

ReleaseID: 603381

DALLAS, TX / ACCESSWIRE / August 26, 2020 / Perimeter Medical Imaging AI, Inc. (TSXV:PINK)(FSE:4PC), a medical technology company driven to transform cancer surgery with advanced, real-time imaging tools to address areas of high unmet medical need, is pleased to announce that Mr. Aaron Davidson has been appointed to the Board of Directors, effective immediately.

Dr. Anthony Holler, Chair of Perimeter's Board of Directors, commented, "I am extremely pleased to welcome Mr. Davidson to our Board. His experience at Profound Medical and extensive knowledge of the medtech landscape is directly relevant to Perimeter, which anticipates a number of near-term clinical development and commercialization catalysts. In addition, Mr. Davidson's work as a partner at H.I.G. BioHealth Partners resulted in numerous success stories in the life sciences sector, and I know Perimeter will benefit from his strategic counsel."

Mr. Davidson stated: "This is an exciting time to join Perimeter's Board of Directors; with clinical studies underway to support the development of its ImgAssist AI software and commercialization plans for its innovative medical imaging system, I look forward to contributing to Perimeter's growth and commercial success."

Mr. Aaron Davidson is CFO and Senior Vice President of Corporate Development of Profound Medical Inc., a medical technology company that is developing real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue. Before joining Profound, Mr. Davidson served as Co-Head and Managing Director of H.I.G. BioHealth Partners, where he focused on investment opportunities with emerging life sciences companies. Mr. Davidson began his career with Eli Lilly and Company, where he spent a decade in various operating management roles in the United States and Canada, including financial management, business development, strategic planning, market research and general management. While at H.I.G., he led investments in, worked with the management teams of, and represented H.I.G. as a board member of several successful companies, including Alder Biopharmaceuticals (public), Forsight Vision5 (acquired), Gemin X Pharmaceuticals (acquired), HyperBranch Medical Technology (acquired), Intact Vascular, OnTarget Laboratories, Novadaq Technologies (public/acquired), and Salmedix (acquired). Mr. Davidson earned his MBA from Harvard Business School and a bachelor's degree in finance from McGill University.

About Perimeter Medical Imaging AI, Inc.
Perimeter Medical Imaging AI (TSXV:PINK)(FSE:4PC) is a Toronto-based company with U.S. headquarters in Dallas, Texas that is developing, with plans to commercialize, advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. Perimeter's OTIS™ platform is a point-of-care imaging system that provides clinicians with real-time, ultra-high-resolution, sub-surface image volumes of the margin (1-2 mm below the surface) of an excised tissue specimen.

The ability to visualize microscopic tissue structures during a clinical procedure in addition to standard of care tissue assessment for decision making during the procedure has the potential to result in better long-term outcomes for patients and lower costs to the healthcare system. Perimeter's OTIS™ platform is cleared by FDA as an imaging tool in the evaluation of excised human tissue microstructure by providing two-dimensional, cross-sectional, real-time depth visualization, with image review manipulation software for identifying and annotating regions of interest. In addition, Perimeter is developing advanced artificial intelligence/machine learning image assessment tools intended to increase the efficiency of review.

Perimeter's ticker symbol "PINK" is a reference to the pink ribbons used during Breast Cancer Awareness Month by the Canadian Cancer Society and the American Cancer Society, driving home the company's dedication to helping surgeons, radiologists and pathologists use Perimeter's imaging technology and AI (Artificial Intelligence) in the fight against breast cancer, which is estimated to account for 30% of all female cancer diagnoses this year.

CONTACT:
Jodi Regts
Corporate Communications / Investor Relations
Perimeter Medical Imaging AI, Inc.
+1 778-999-5634
media@perimetermed.com

NEITHER THE TSXV NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSXV) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

This news release contains statements that may constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. In this news release, words such as "may", "would", "could", "will", "likely", "believe", "expect", "anticipate", "intend", "plan", "estimate" and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking information may include, among others, statements regarding the timing and results from clinical studies, commercialization plans, and future growth, or the assumptions underlying any of the foregoing.

Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, such future performance will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management's good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions and other unpredictable factors, many of which are beyond Perimeter's control. Such forward-looking statements reflect Perimeter's current view with respect to future events, but are inherently subject to significant medical, scientific, business, economic, competitive, political and social uncertainties and contingencies.

In making forward-looking statements, Perimeter may make various material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market and economic conditions. Further risks, uncertainties and assumptions include, but are not limited to, those applicable to Perimeter and described the joint information circular dated May 12, 2020, prepared in respect of the securityholder meetings held on June 17, 2020 a copy of which is available on Perimeter's SEDAR profile at www.sedar.com, and could cause actual events or results to differ materially from those projected in any forward-looking statements. In particular, we note the risk that our technology may not achieve the anticipated benefits in terms of surgical outcomes. Perimeter does not intend, nor does Perimeter undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events or circumstances or otherwise, except if required by applicable laws.

SOURCE: Perimeter Medical Imaging

ReleaseID: 603366

LAS VEGAS, NV / ACCESSWIRE / August 26, 2020 / GB Sciences, Inc. (OTCQB:GBLX) has filed a provisional patent application, assigned to GBS Global Biopharma (GBS), Inc., for the use of its new proprietary cannabinoid containing complex mixtures (CCCM™) for the treatment of Cytokine Storm Syndromes (CSS), including acute respiratory distress syndrome (ARDS) in COVID-19 patients. CSS and ARDS are the leading cause of death in COVID-19. Based on data obtained from GBS's two-year study on the use of cannabis-based ingredients for modulating inflammatory processes within human immune cells, GBS's CCCM™ were designed to reduce levels of specific cytokines and pro-inflammatory processes triggered by SARS-CoV-2 infections, while preserving those immune functions and cytokines that are necessary for fighting the viral infection.

"Our CCCM™ are cannabis-based combination therapies designed to target key cytokines that correlate with symptom severity in COVID-19 patients and are known to cause Cytokine Storm Syndromes, which may lead to hospitalization or even death. However, treatment of virally induced Cytokine Storm Syndromes in COVID-19 patients may not be as simple as using a broadly immunosuppressive strategy because the production of specific pro-inflammatory cytokines may be crucial for immune defense against SARS-CoV-2 infections, or other viral infections in the future," explained Dr. Andrea Small-Howard, Chief Science Officer and Director of both GB Sciences, Inc. and GBS Global Biopharma, Inc. "GBS's CCCM™ are also being developed as an adjunctive therapy to be delivered to COVID-19 patients in combination with clinically (FDA)-approved Interferon products for the most beneficial patient results – reduced Cytokine Storm Syndrome while preserving the anti-viral immune processes necessary for fighting viral infections."

Inflammatory disorders represent a serious global health and economic burden with over $200 billion spent annually. The current COVID-19 pandemic has created an increased demand for novel anti-inflammatory treatments to combat the effects of the severe forms of COVID-19.

"These novel CCCM™ represent a much-needed alternative for the treatment of inflammatory disorders, including COVID-19 and many other serious conditions," said Dr. Michael Farley, President and Director of GBS Global Biopharma.

"This is a big deal. In plain English, our combinations of specific cannabinoids and terpenes were designed to quiet the immune system's storm without totally disabling the immune system," said John Poss, CEO and Chairman of GB Sciences.

In addition to this new provisional patent application, GBS's intellectual property portfolio currently contains four patents that are issued in the U.S. with corresponding patents issued internationally. Seven nonprovisional patent applications plus three provisional patent applications are pending in the U.S. and 29 patent applications have been filed internationally.

About GB Sciences, Inc. and GBS Global Biopharma, Inc.

GB Sciences, Inc. (OTCQB:GBLX), through its Canadian entity GBS Global Biopharma, Inc., is a dedicated biopharmaceutical research and cannabinoid-based drug development company whose goal is to create patented formulations for safe, standardized, cannabinoid therapies that target a variety of medical conditions in both the pharmaceutical and wellness markets.

Forward-Looking Statements

This press release may contain statements relating to future results or events, which are forward-looking statements. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company's belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company's control. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the Company and its business, including factors that potentially could materially affect the Company's business and financial and other results, are contained in the Company's filings with the Securities and Exchange Commission, available at www.sec.gov. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.

Contact Information

GB Sciences, Inc.
3550 West Teco Avenue
Las Vegas, NV 89118
866-721-0297

GBS Global Biopharma, Inc.
200-900 Morrison Drive
Ottawa, Ontario K2H8K7

Michael Farley, Ph.D., President & Director
michael@gbsglobalbiopharma.com

SOURCE: GB Sciences, Inc.

ReleaseID: 603407

Skin Science Soul by Dr. Sholar is proud to provide a variety of services to keep patients feeling beautiful and confident

AUSTIN, TX / ACCESSWIRE / August 26, 2020 / As a modern, state of the art facility, Skin Science Soul is happy to offer the most up to date plastic surgery and aesthetic medical procedures. Dr. Alina Sholar does her best to ensure Skin Science Soul provides the latest trends and services in aesthetic medicine. She vets every new treatment and technology that is on the scene and is choosey about what she offers her patients.

Dr. Alina Sholar is a respected plastic surgeon, female entrepreneur, and mentor with more than 20 years of experience. Dr. Sholar currently owns Skin Science Soul by Dr. Sholar, Serenity Medical Centers, and Sage Practice Solutions.

Some of the newest procedures offered by Skin Science Soul include VirtueRF Microneedling, Tetra CoolPeel, SubNovii Plasma Pen, EMsculpt Body Sculpting, and SkinWave Hydrofacial Treatment.

Dr. Alina Sholar is particularly excited by the latest trends in aesthetic medicine and the latest technological innovations in non-invasive, non-surgical skin and body rejuvenation.

"In my office, we understand the science behind the tech and the biology beneath the skin to really make our patients' results far beyond what your average medspa could ever offer," says Dr. Alina Sholar.

She notes that by offering the latest services, she and her team are able to see the amazing transformations among patients.

"This is just as fulfilling for our staff, too. That excitement from the patient drives them to learn more and perform better every day," says Dr. Sholar.

For more information, please visit https://www.skinsciencesoul.com/.

About Dr. Alina Sholar

Throughout her illustrious career, Dr. Alina Sholar has made a name for herself as a respected plastic surgeon, female entrepreneur, and mentor. She attended Texas A&M University on a full-tuition merit scholarship and earned a B.S. degree in Biomedical Science with Magna Cum Laude honors in 1994. In 1999, she earned her MD degree from the University of Texas Medical Branch, where she was also awarded the prestigious Janet M. Glasgow Memorial Award and Achievement Citation for Women in Medicine. She then completed a full five-year residency in General Surgery at the University of Louisville, where she was awarded Best Resident Instructor and Mentor by the students of the University of Louisville School of Medicine. She also completed an additional residency in Plastic and Reconstructive Surgery at the University of Tennessee, serving as Chief Resident in 2006. She received multiple awards and publications in research areas such as the efficacy of treatment at Tertiary Care Wound Centers and the advanced reconstructive techniques required after major facial trauma and infections. She was certified by the American Board of Plastic Surgery in 2008. Dr. Sholar currently owns Skin Science Soul by Dr. Sholar, her plastic surgery and medical aesthetic practice. She is also the owner and CEO of Serenity Medical Centers and Sage Practice Solutions. Dr. Sholar also provides pro bono business consulting for women entrepreneurs in need. Further, she mentors young female physicians and non-physician entrepreneurs. Dr. Sholar is also a philanthropist and regularly gives back to her local communities, supporting women-owned businesses and organizations that benefit women and children.

Contact:

Dr. Alina Sholar
512-712-6117
https://www.linkedin.com/in/dr-alina-sholar-md-379b0422/

SOURCE: Dr. Alina Sholar

ReleaseID: 603450

Major carbon brush manufacturers are investing in research for new materials to manufacture components, aimed towards superior functionality in a competitive market landscape.

DUBAI, UAE / ACCESSWIRE / August 26, 2020 / The global carbon brush market is expected to grow 1.4x between 2019 and 2029, with a moderate 4% CAGR. The global coronavirus outbreak is expected to have a significant impact on the carbon brush market, largely owing to disrupted activities in the automotive, industrial, and consumer goods sectors. Disruptions in supply chains involving Chinese producers could also affect short term developments.

"Carbon brushes are characterized by superior temperature resistance and electric conductivity. These products also display a lower coefficient of friction and lower modulus of elasticity which bolsters demand in the automotive and industrial sector, supporting market growth during the projection period," says the FMI study.

For more insights into the Market, Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1047

Carbon Brush Market – Key Takeaways

Graphite based carbon brushes account for significant revenue, supported by cost and durability benefits.
Automotive production applications hold major market share, with transition towards electric vehicles.
Asia Pacific is a leading market for carbon brushes owing to its massive manufacturing sector consumer base.

Carbon Brush Market – Key Driving Factors

Frequent innovations in the consumer appliances sector is a major factor driving adoption of carbon brushes.
Steady growth of global industrial economy sustains long-term demand for carbon brushes.

Carbon Brush Market – Key Constraints

Limited scope for innovations in carbon brushes holds back market growth, and provides impetus to alternatives.
Poor performance in high-density settings restrict sales and application of carbon brushes.

For information on the Research Approach used in the Report, Request Methodology@ https://www.futuremarketinsights.com/askus/rep-gb-1047

The Anticipated Impact of Coronavirus

The coronavirus pandemic has adversely affected the global economy and industrial activity. Manufacturing, automotive, and consumer goods sectors have been hit especially hard with disruptions in supply chains, production activity, and shortage of labor. All of these factors will result in a sharp decline in the demand for carbon brushes in the short term, for the duration of the outbreak. Demand is likely to recovery strongly towards 2021 as governments relax lockdown restrictions.

Competition Landscape

Major manufacturers in the carbon brush market include but are not limited to Assam Carbon Products Ltd., Morgan Advanced Materials, National Carbon Brush Products, Mersen SA, Phynyx Industrial Products Pvt. Ltd., Schunk GmbH, Robert Bosch GmbH, and Naeem Carbon & Industrial Products LLP.

Carbon brush manufacturers have been investing in expansion of production capabilities in addition to the integration of tech improvements as strategies to bolster sales and profit margins.

For instance, Mogan Advanced Materials have come up with a new drop in replacement carbon holder system for wind turbine applications. Schunk GmbH has set up a new production facility in Franconia Germany which will include carbon brush manufacturing. Also, Helwig Carbon Products has announced the manufacturing line of J. Ream Manufacturing in Illinois for carbon brush holders.

For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-1047

More About the Report

The FMI's market research report offers detailed insights on carbon brush market. The market is scrutinized on the basis of product type (general graphite, metal graphite, carbon graphite, electro graphite, silver graphite, resin-bonded graphite, and others), application (motor, generator & alternator, current & signal transmission, grounding devices, and others), sales channel (OEM and aftermarket) and end use (automotive, electrical hand tools, industrial application, household appliances, security & defense, petrochemical, energy, and healthcare), across seven key regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East and Africa).

Explore Extensive Coverage of FMI's Industrial Automation and Equipment Landscape

Lead Acid Battery Market: Find insights on the global lead acid battery market with segment analysis, statistics, influencing factors, and business strategies for a 10-year projection period.

Telecom Tower Power Systems Market: FMI's report on the telecom tower power systems market offers details on the market during 2015-2025. The study covers impacting forces, sources of revenue, market leaders, and market strategies.

Heat Recovery Steam Generator Market: Get an in-depth analysis on the heat recovery steam generator market with insights on growth levers, regulations, restraints, regional markets and market leaders between 2017 and 2027.

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/carbon-brush-market
Press Release Source: https://www.futuremarketinsights.com/press-release/carbon-brush-market

SOURCE: Future Market Insights

ReleaseID: 603429

TORONTO, ON / ACCESSWIRE / August 26, 2020 / Toronto based CO2 GRO Inc. ("GROW") (TSXV:GROW)(OTCQB:BLONF)(FRA:4021) is pleased to announce that it will install a CO2 Delivery Solutions™ VCO2 system for a Commercial Feasibility at one of Hidroexpo S.A. de C.V.'s ("Hidroexpo") 1-hectare peppers greenhouse in El Salvador. Hidroexpo operates over thirty 1-hectare greenhouses all growing peppers for export to the U.S. primarily through large food distributors such as Lipman Family Farms ("Lipman") who facilitated the introduction.

The Commercial Feasibility will begin in September 2020 for one complete grow season ending in April 2021. Objectives are to assess faster time to harvest, increased pepper yield per harvest, Perimeter Protection™ against the spread of microbial pathogens and CO2 gas usage.

Lipman Family Farms owns and operates greenhouses throughout the U.S. and Canada growing a variety of produce, as well as sourcing produce from contract growers in El Salvador (Hidroexpo) and Mexico. Most greenhouses in Central and South America do not practice atmospheric enrichment of CO2 by gassing as they are open venting designs and CO2 costs are generally more expensive than in North America. GROW's CO2 Delivery Solutions™ enables these greenhouses to supplement their plants with CO2 by misting an aqueous CO2 solution directly on to the plants, regardless of the greenhouse design. Aqueous CO2 misting significantly reduces CO2 usage and costs by over 90% compared to gassing, making CO2 Delivery Solutions™ the only practical and economical method to provide CO2 to plants for greenhouses in those regions.

Rodrigo Martinez, General Manager of Hidroexpo commented, "As an innovative company, we have been searching for solutions to increase the CO2 for our plant growth. In a hot climate it is very difficult to maintain air flow while adding more CO2 in the greenhouse atmosphere. We are very excited to test the CO2 Delivery Solutions™ system as it will help us increase our production while keeping our costs low."

According to John Archibald, GROW's CEO, "We are thankful to Lipman for the introduction to Hidroexpo. This is a large commercial vegetable grower in Central America servicing both North American and South American food distributors. Success of our largest Commercial Feasibility to date will enhance the adoption of our CO2 Delivery Solutions™ systems by providing visibility of our technology's potential to major food distributors that operate North, Central and South American greenhouses."

Visit www.co2delivery.ca for more information on CO2 Delivery Solutions™ or watch this video. To see CO2 Delivery Solutions™ set up at Sacred Seeds, watch this video and skip to minute 2 and 4.30.

About CO2 GRO Inc.

GROW's mission is to accelerate the growth of all value plants safely, effectively and profitably using our patent protected advanced CO2 Delivery Solutions™. It is a commercially proven technology that is easily adopted into all covered cultivation including greenhouses, shade, hoop and tunnel houses, indoor and outdoor grow operations.

GROW's target markets are the 50 billion square feet of global greenhouse space (USDA) and the highest value crops within 4.62 billion acres of global cropland (USGS). While indoor gassing of CO2 to enhance crop yields has been practiced for decades, 85% of the world's greenhouses cannot use CO2 gassing economically due mostly to heat ventilation which causes the CO2 gas to escape. Outdoor growers cannot gas CO2 into the atmosphere to the ideal levels required of up to 1500 ppm.

GROW's CO2 Delivery Solutions™ naturally and safely dissolves CO2 gas into water creating an aqueous CO2 solution which is then misted directly on plant leaves. GROW has demonstrated improving crop yields by up to 30% with up to 30% faster growth. The CO2 solution's micro droplets create an aqueous film around the entire leaf surface, isolating the leaf from the atmosphere. This creates a diffusion gradient favoring CO2 transport into the leaf and other gases out of the leaf. Increased carbon availability enhances photosynthesis resulting in faster and larger plant growth. CO2 Delivery Solutions™ has been demonstrated on crops including cannabis, lettuce, kale, microgreens, peppers and flowers. Growers everywhere can now supplement CO2 to their crops using CO2 Delivery Solutions™, increasing plant yields and profits.

Forward-Looking Statements This news release may contain forward-looking statements that are based on CO2 GRO's expectations, estimates and projections regarding its business and the economic environment in which it operates. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. Statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.  

For more information, please visit www.co2gro.ca or contact Sam Kanes, VP Communications at 416-315-7477 or Michael O'Connor, Manager of IR at 604-317-6197.  

SOURCE: CO2 Gro Inc.

ReleaseID: 603418

80% organic rev growth from San Diego Farmers Outlet; outperforming growth of newly acquired Seaport Meats validates M&A strategy

LOS ANGELES, CA / ACCESSWIRE / August 26, 2020 / Pacific Ventures Group, Inc. (OTC PINK:PACV) (the "Company"), a food and beverage holding company specializing in the distribution of consumer food, beverage and alcohol-related products, is pleased to announce the Company's financial results for the second quarter ended June 30, 2020.

Key Financial Highlights for Q2 2020:

Revenues increased 671% over Q2 2019 to $8.7 million
Gross profit increased 145% to $1.0 million

Key Financial Highlights for 1st Half 2020:

Revenues increased 536% over 1st Half 2019 to $15.4 million
Gross profit increased 193% to $2.0 million

Revenue growth was driven by 80% increase from San Diego Farmers Outlet and the acquisition of Seaport Meat Company, which closed in December 2019. Because Seaport Meat Company can efficiently add new product lines, it is expected that this will expand the distribution of San Diego Farmers Outlet and SnoBar product line, thereby accelerating Pacific Ventures' revenue growth. We believe this combination of a distribution and product company is unique in the San Diego area and will accelerate our growth.

Of note, from January 1, 2020 through June 30, 2020, the Company issued 0 shares of its common stock.

Management Commentary
Ms. Shannon Masjedi, Pacific Venture Group's Chief Executive Officer, commented, "I am extremely pleased with our first half 2020 results, as we continue to execute on our plans since integrating Seaport Meat Company, implementing efficiencies and executing growth initiatives. Our strategic plan is proving itself with the dramatic revenue increase to $15.4 million in the first half of 2020."

Masjedi, continued, "Our Company is well-positioned for further growth in 2020 and 2021. We intend to achieve operating cash flow breakeven in the next 12 months. Our team and advisors continue work on further improving our balance sheet and positioning us for an uplist to a major national stock exchange in 2021.

Masjedi, concluded, "We have a three-prong growth strategy (1) incrementally accelerate sales and improve profitability of San Diego Farmers Outlet and Seaport Meat Company, (2) expand Snöbar production and distribution and (3) acquire additional food production or distribution companies synergistic with existing assets. Our management team and Board continue to assess and vet a robust potential M&A pipeline to complement our organic growth. We look forward to reporting our progress as it unfolds throughout the remainder of 2020."

Snobar Update
As of today, Snöbar products are currently being sold in the east coast of United States by the Company's distributor. We have been actively constructing an online platform that will allow Snöbar distribution on a national level. The Company's platform is complete and ready to "go live" and, with the aim of purchasing inventory as well as increasing sales and marketing efforts.

The Company has recently signed an agreement with a new co-packer to produce and manufacture the Snobar Product Line. The new factory will produce the Snobar Product Line for a reduced price which will allow for greater profitability for the company. The new factory has all of the necessary licensing in place required to manufacture the Snobar Product Line.

In addition, the Company is planning to offer distribution rights throughout the country which will allow the Snöbar Product Line to expand its footprint very rapidly. The distribution rights will also bring in additional revenue to the Company.

Financial Results for the Three Months Ended June 30, 2020:
Revenue for the three months ended June 30, 2020 was $8.7 million, an increase of $7.6 million, or 671%, as compared to $1.1 million for the three months ended June 30, 2019. The increase in revenue was driven by 80% organic growth at San Diego Farmers Outlet and the acquisition of Seaport Meat Company, which closed in December 2019.

Gross profit for the three months ended June 30, 2020 was $1.0 million, compared to $0.3 million for the three months ended June 30, 2019. The resulting gross margin was 11.6% for the three months ended June 30, 2020, compared to 36.4% for the three months ended June 30, 2019. The increase in gross profit and decline in gross margin is due to the higher revenue but lower margin business model of Seaport Meat Company.

Operating expenses for the three months ended June 30, 2020 were $1.7 million, an increase of $1.2 million, or 247%, compared to $0.5 million for the three months ended June 30, 2019. The increase primarily related to an increase in operating activities and an increase in salaries and wages due to the acquisition of Seaport Meat Company, which closed in December 2019.

Operating loss for the three months ended June 30, 2020 was $0.7 million, an increase of $0.6 million, or 836%, compared to $0.1 million for the three months ended June 30, 2019.

Interest expense for the three months ended June 30, 2020 was $0.4 million, an increase of $0.2 million, or 150%, compared to $0.2 million for the three months ended June 30, 2019.

Net loss for the three months ended June 30, 2020 was $1.1 million, an increase of $0.8 million, or 352%, compared to $0.2 million for the three months ended June 30, 2019. The resulting loss per share for the three months ended June 30, 2020 was ($0.94) per diluted share, compared to ($0.00) per diluted share for the three months ended June 30, 2019.

Financial Results for the Six Months Ended June 30, 2020:
Revenue for the six months ended June 30, 2020 was $15.4 million, an increase of $13.0 million, or 536%, as compared to $2.4 million for the six months ended June 30, 2019. The increase in revenue was driven by 80% organic growth at San Diego Farmers Outlet and the acquisition of Seaport Meat Company, which closed in December 2019.

Gross profit for the six months ended June 30, 2020 was $2.0 million, compared to $0.7 million for the six months ended June 30, 2019. The resulting gross margin was 13.1% for the six months ended June 30, 2020, compared to 28.5% for the six months ended June 30, 2019.

Operating expenses for the six months ended June 30, 2020 were $3.1 million, an increase of $2.2 million, or 249%, compared to $0.9 million for the six months ended June 30, 2019. The increase primarily related to an increase in operating activities and an increase in salaries and wages due to the acquisition of Seaport Meat Company, which closed in December 2019.

Operating loss for the six months ended June 30, 2020 was $1.1 million, an increase of $0.9 million, or 446%, compared to $0.2 million for the six months ended June 30, 2019.

Interest expenses for the six months ended June 30, 2020 was $0.8 million, an increase of $0.4 million, or 126%, compared to $0.4 million for the six months ended June 30, 2019.

Net loss for the six months ended June 30, 2020 was $1.9 million, an increase of $1.3 million, or 244%, compared to $0.5 million for the six months ended June 30, 2019. The resulting loss per share for the six months ended June 30, 2020 was ($1.63) per diluted share, compared to ($0.00) per diluted share for the six months ended June 30, 2019.

About Pacific Ventures Group, Inc.
Pacific Ventures Group, Inc. (OTC PINK:PACV) is focused on expansion within the consumer products, food, beverage and alcohol-related industries. For more information on PACV, please visit www.pacvgroup.com. (You need to be at least 21 years of age (legal age to consume alcohol) to visit the section of the web site dedicated to SnöBar.)

Safe Harbor Statement
Forward-Looking Statement: This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that such forward-looking statements involve risks and uncertainties, which include but are not limited to, the inability of the company to obtain financing sufficient to maintain its operations and execute its acquisition strategy; the inherent uncertainties associated with smaller reporting companies; and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.

Investors Contact:
ir@pacvgroup.com

ClearThink
nyc@clearthink.capital

SOURCE: Pacific Ventures Group INC

ReleaseID: 603416

WOODINVILLE, WA / ACCESSWIRE / August 26, 2020 / Deep Green Waste & Recycling, Inc. (OTC PINK:DGWR), a sustainable waste and recycle management services company for commercial customers, today announces that it signed a Letter of Intent (LOI) to acquire the assets of Amwaste, Inc., a commercial waste and debris disposal services company serving the Golden Isles region of coastal Georgia.

Based in Brunswick, Georgia, Amwaste serves customers in Glynn County and surrounding areas, where the company has built a solid customer base and has established a strong reputation for quality service. Amwaste operates in a vibrant, high-growth area of the southeastern United States and will be a key element for developing Deep Green's business.

"This acquisition is strategic because it will help us expand our footprint for delivering innovative waste and recycle management services to commercial customers in Georgia while executing an important step in our growth strategy," said Lloyd Spencer, president and CEO of Deep Green. "We look forward to bringing Amwaste into the Deep Green family and developing Amwaste to its fullest potential."

Deep Green expects to sign a Definitive Asset Purchase Agreement after completing its due diligence.

About Amwaste, Inc.
Amwaste, Inc. is an established commercial waste and debris disposal services company serving the Golden Isles region of coastal Georgia. For more information, visit: https://www.callamwaste.com.

About Deep Green Waste & Recycling, Inc.
Deep Green Waste & Recycling, Inc. (OTC PINK:DGWR) is reestablishing itself as an innovative waste and recycling company which provides sustainable waste and recycle management services, and helps commercial customers realize cost-savings using streamlined processes that help reduce, re-purpose and recycle waste. For more information, visit: https://DeepGreenWaste.com.

SAFE HARBOR STATEMENT
This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results or implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

For information, please contact:
Lloyd Spencer, President
Deep Green Waste & Recycling, Inc.
13110 NE 177th Place, #293
Woodinville, WA 98072
Phone: (833) 304-7336 / (833) 30-GREEN
Email: Investor@DeepGreenWaste.com

SOURCE: Deep Green Waste & Recycling

ReleaseID: 603408